Trade-Ideas LLC identified Questcor Pharmaceuticals Inc (NASDAQ:QCOR) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Questcor Pharmaceuticals as such a stock due to the following factors: QCOR has an average dollar-volume; QCOR is trading at a new lifetime high. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) net profit margin is 36.80% and weekly performance is 6.49%. On last trading day company shares ended up $87.62. Analysts mean target price for the company is $86.43. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) distance from 50-day simple moving average (SMA50) is 22.13%.
In the quarter, Hologic, Inc. (NASDAQ:HOLX)’s key products, especially 3D mammography and Aptima HPV, gained momentum. In the diagnostics business, the Japanese Red Cross (JRC) selected Hologic’s new collaboration partner, Grifols to screen the country’s 5.3 million annual blood donations. According to Hologic, this represents a strong win and validation of Hologic’s Panther system. Hologic, Inc. (NASDAQ:HOLX) shares fell -1.35%in last trading session and ended the day on $24.18. HOLX Gross Margin is 47.80% and its return on assets is -12.70%. Hologic, Inc.(NASDAQ:HOLX) quarterly performance is 16.53%.
Mallinckrodt PLC (NYSE:MNK), a leading global specialty pharmaceutical company, reported results for the second quarter of fiscal 2014.The company also announced that it revised and increased guidance for fiscal 2014 reflecting the strong performance of the company’s base business and the recently completed acquisition of Cadence Pharmaceuticals. Mallinckrodt PLC (NYSE:MNK) shares moved up 0.91% in last trading session and was closed at $75.10, while trading in range of $75.05 – $77.91. Mallinckrodt PLC (NYSE:MNK) year to date (YTD) performance is 43.70%.
Novartis AG (ADR) (NYSE:NVS) and fellow drug company Roche are facing scrutiny from the European authorities over possible collusion in the marketing of two drugs. The two companies are already being investigated in a number of countries in Europe over the same concerns. Novartis AG (ADR)(NYSE:NVS) ended the last trading day at $87.91. Company weekly volatility is calculated as 0.81% and price to cash ratio as 30.83. Novartis AG (ADR) (NYSE:NVS) showed a positive weekly performance of 1.05%.